Xiaoxue Ren

789 citations
9 papers · 373 indexed · 1 hit paper · h-index 6
Topics
Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers)Immune cells in cancer (2 papers)Cancer Genomics and Diagnostics (2 papers)
Partner nations
ChinaHong KongSingapore

In The Last Decade

Xiaoxue Ren

9 papers receiving 371 citations

Hit Papers

N7-Methylguanosine tRNA modification enhances oncogenic m...2021202620222024202150100150200

Peers

Xiaoxue Ren
Comparison fields: 5 of 41
  • Molecular Biology 234
  • Cancer Research 133
  • Oncology 118
  • Immunology 49
  • Pulmonary and Respiratory Medicine 40
Replace Xuxin Ren with:
Xuxin Ren China
Dennis Poel Netherlands
Mara Persano Italy
Zuoxing Niu China
Guoli Shao China
Betül Gök Yavuz United States
Wei Luan China
Xinrui Mao China
Yunshi Zhong China
Jianmin Wu China
Xiaoxue Ren relative to Xuxin Ren China Xuxin Ren's profile →
Citations per field
00.5×
Xuxin Ren · 1×
Citations per year

Countries citing papers authored by Xiaoxue Ren

Since Specialization
Citations

This map shows the geographic impact of Xiaoxue Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxue Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxue Ren more than expected).

Fields of papers citing papers by Xiaoxue Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxue Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxue Ren. The network helps show where Xiaoxue Ren may publish in the future.

Co-authorship network of co-authors of Xiaoxue Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxue Ren. A scholar is included among the top collaborators of Xiaoxue Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxue Ren. Xiaoxue Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 2
2 1
3 29
4 33
5 10
6 1
7 52
8 44
9
N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progressionbreakdown →
201

About Xiaoxue Ren

Xiaoxue Ren is a scholar working on Cancer Research, Oncology and Hepatology, having authored 9 papers that have together received 373 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Immune cells in cancer (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (133 citations), Hepatology (35 citations) and Oncology (118 citations). Xiaoxue Ren has collaborated with scholars based in China, Hong Kong and Singapore. Frequent co-authors include Lixia Xu, Sui Peng, Jiaming Lai, Shenghua Zhu, Baogang Peng, Ming Kuang, Xiaoxing Li, Wanjie Zhu, Shuibin Lin and Cheng Huang. Their work appears in journals such as Molecular Cell, Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026